| abstract |
The present invention relates to a method for identifying novel mechanisms of transcriptional inaccuracy in cells. The present invention relates to compositions and methods for examining the level of transcriptional inaccuracy in a sample, as well as their use in treatment, diagnosis, pharmacogenomics or drug design. As described, the present invention is particularly suitable for detecting, monitoring or treating proliferative cell disease in patient profiling, prediction of disease severity and evaluation of drug efficacy, for the design and / or screening of drugs. Do. |